Samsara BioCapital »

Alumis shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2024-09-30 $35M 3.3M 10.68

More positions owned by Samsara BioCapital

Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Scholar Rock Hldg Corp (SRRK)
Neurogene (NGNE)
Alumis Common Stock (ALMS)
Arcellx Common Stock (ACLX)
Lenz Therapeutics (LENZ)
Nkarta (NKTX)
Eliem Therapeutics (ELYM)
Avadel Pharmaceuticals Com Shs (AVDL)
Zymeworks Del (ZYME)
Acelyrin (SLRN)
Contineum Therapeutics Cl A (CTNM)
Jasper Therapeutics Com New (JSPR)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Alumis

AyurMaya Capital Management Company
Foresite Capital Management V
Samsara BioCapital
venBio Partners
Cormorant Asset Management
Sr One Capital Management
Baker Bros. Advisors
Nextech Invest
BlackRock
Omega Fund Management
Tang Capital Management
TowerView
Morgan Stanley
Geode Capital Management
Iron Triangle Partners

View all funds holding Alumis